PLOS ONE 润色咨询

PLoS One

出版年份:2006 年文章数:239709 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2024-03-25 tuo35 来自广西

    偏重的研究方向:分子生物学;肿瘤
    经验分享:能够accept

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2021-11-14 1259e63fm64暂无昵称

    偏重的研究方向:命苦
    经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2021-10-29 crystal-

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:分子生物
    经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2022-01-12 洛洛仔

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤学
    经验分享:9月底投稿,至今5个月了还在under review

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2023-07-06 presson 来自上海

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2023-10-27 ms5000001328224209 来自黑龙江省

    2月21日投稿
    7月25日返审稿意见,大修
    9月8日提交修改稿+回答审稿人意见
    9月26日接收
    10月10日改格式,校稿
    10月21日交版面费
    10月26日见刊

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2024-03-04 隔壁王校长 来自浙江省

    投了一篇孟德尔,祝好运

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2024-03-05 ms1000000466115089 来自四川省

    请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2023-12-03 ms2000001891239095 来自辽宁省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195230, encodeId=f30f2195230cf, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:能够accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/01aad4abd2a044ac946891d11f8d9121-8Ak2X7NRQQiJ.jpg, createdBy=95229213800, createdName=tuo35, createdTime=Mon Mar 25 14:49:22 CST 2024, time=2024-03-25, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1070138, encodeId=a52d10e0138de, content=偏重的研究方向:命苦<br>经验分享:投了2篇在PLOS ONE,第一篇7月投稿,已经under review3个月的时候催稿信发过去就是还在审,缺审稿人,推荐了审稿人,又不接受我的推荐,现在已经4个月了,一审结果都没返回。然后手贱,10月又投了一篇,现在已经editor invited一个月了,后悔的一米,当时就不应该两个文章都投这个期刊的,把所有希望都放在这一个期刊上,后悔不已,还等着毕业的。审稿速度不是一般的慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Sun Nov 14 13:10:41 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064872, encodeId=9dea10648e201, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:分子生物<br>经验分享:投了一篇,外审3个月,反修一次录用,投稿到见刊4个月,还挺快,值得注意的是plos one录用后修改格式那一次就是最后一次修改机会,然后直接见刊,导致我没机会修改几个小问题,总的来说还行,录用量直线下跌,继续保持应该算是潜力股吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=820e5536674, createdName=crystal-, createdTime=Fri Oct 29 02:11:54 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183639, encodeId=dfcd118363999, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:9月底投稿,至今5个月了还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Wed Jan 12 20:23:58 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146568, encodeId=1160214656846, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:2月投稿,到现在还在外审,服了,真的特别的慢,催了几次不敢催了,怕给我退了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Thu Jul 06 08:06:11 CST 2023, time=2023-07-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165218, encodeId=996b216521874, content=2月21日投稿<br>7月25日返审稿意见,大修<br>9月8日提交修改稿+回答审稿人意见<br>9月26日接收<br>10月10日改格式,校稿<br>10月21日交版面费<br>10月26日见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc256407206, createdName=ms5000001328224209, createdTime=Fri Oct 27 12:47:21 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2190897, encodeId=78a8219089e56, content=投了一篇孟德尔,祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Mon Mar 04 11:54:33 CST 2024, time=2024-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172700, encodeId=688221e2700b8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:3月末投稿,6月初有反馈,major revision, 改完了居然就接受了,发的meta,话说这个期刊水么?是不是预警过?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d24e8456612, createdName=ms2000001891239095, createdTime=Sun Dec 03 15:15:14 CST 2023, time=2023-12-03, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182493, encodeId=b748218249365, content=偏重的研究方向:综合<br>经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Thu Jan 18 21:43:45 CST 2024, time=2024-01-18, status=1, ipAttribution=安徽省)]
    2024-01-18 ms7000001152426712 来自安徽省

    偏重的研究方向:综合
    经验分享:大家预接收后,都是多久收到正式接收呀? 12月29预接收后修改返回出版部门,到现在一点消息没有了。

    8

    展开8条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分